Skip to main content

Vandervoort Adam C's Form 4 filing

Teladoc Health, Inc. (TDOC) · filed Jun 3, 2026

Accession no.
0001375088-26-000004
Filed
Jun 3, 2026
Trade date
Jun 1-2, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $60.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Vandervoort Adam CCIK 0001375088Officer (CHIEF LEGAL OFFICER, SECRETARY)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 1, 2026Common StockMOption exerciseAcquired+426––103,665Direct
Jun 1, 2026Common StockMOption exerciseAcquired+5,350––109,015Direct
Jun 1, 2026Common StockMOption exerciseAcquired+9,152––118,167Direct
Jun 2, 2026Common StockSSaleDisposed−7,906$7.63−$60,322.78110,261Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 1, 2026Common StockMOption exerciseDisposed−426$0.00$02,979Direct
Jun 1, 2026Common StockMOption exerciseDisposed−5,350$0.00$016,050Direct
Jun 1, 2026Common StockMOption exerciseDisposed−9,152$0.00$064,070Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)